Asimov Press • 193 implied HN points • 03 Nov 24
- Tuberculosis (TB) is still a major global health threat, killing around 1.2 million people each year despite vaccines and antibiotics that help in treatment. There is a pressing need for new medicines and vaccines to reduce TB cases and deaths significantly.
- The current BCG vaccine against TB has varied effectiveness, especially in adults, and has not been updated for decades. Newer vaccine candidates like M72/AS01E are being developed to provide better protection, particularly for adults.
- Antibiotic resistance in TB is a growing concern, making it harder to treat. New strategies to discover antibiotics and improve existing treatments are crucial for combating resistant strains of TB and ensuring effective patient care.